221 related articles for article (PubMed ID: 37670055)
1. Inhibition of ACSL4 ameliorates tubular ferroptotic cell death and protects against fibrotic kidney disease.
Dai Y; Chen Y; Mo D; Jin R; Huang Y; Zhang L; Zhang C; Gao H; Yan Q
Commun Biol; 2023 Sep; 6(1):907. PubMed ID: 37670055
[TBL] [Abstract][Full Text] [Related]
2. Fisetin ameliorates fibrotic kidney disease in mice via inhibiting ACSL4-mediated tubular ferroptosis.
Wang B; Yang LN; Yang LT; Liang Y; Guo F; Fu P; Ma L
Acta Pharmacol Sin; 2024 Jan; 45(1):150-165. PubMed ID: 37696989
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of ACSL4 attenuates ferroptotic damage after pulmonary ischemia-reperfusion.
Xu Y; Li X; Cheng Y; Yang M; Wang R
FASEB J; 2020 Dec; 34(12):16262-16275. PubMed ID: 33070393
[TBL] [Abstract][Full Text] [Related]
4. Novel aspect of neprilysin in kidney fibrosis via ACSL4-mediated ferroptosis of tubular epithelial cells.
Lai W; Huang R; Wang B; Shi M; Guo F; Li L; Ren Q; Tao S; Fu P; Ma L
MedComm (2020); 2023 Aug; 4(4):e330. PubMed ID: 37457659
[TBL] [Abstract][Full Text] [Related]
5. Liproxstatin-1 attenuates unilateral ureteral obstruction-induced renal fibrosis by inhibiting renal tubular epithelial cells ferroptosis.
Zhang B; Chen X; Ru F; Gan Y; Li B; Xia W; Dai G; He Y; Chen Z
Cell Death Dis; 2021 Sep; 12(9):843. PubMed ID: 34511597
[TBL] [Abstract][Full Text] [Related]
6. Ischemia-induced ACSL4 activation contributes to ferroptosis-mediated tissue injury in intestinal ischemia/reperfusion.
Li Y; Feng D; Wang Z; Zhao Y; Sun R; Tian D; Liu D; Zhang F; Ning S; Yao J; Tian X
Cell Death Differ; 2019 Nov; 26(11):2284-2299. PubMed ID: 30737476
[TBL] [Abstract][Full Text] [Related]
7. YAP/ACSL4 Pathway-Mediated Ferroptosis Promotes Renal Fibrosis in the Presence of Kidney Stones.
Li L; Ye Z; Xia Y; Li B; Chen L; Yan X; Yuan T; Song B; Yu W; Rao T; Lin F; Zhou X; Cheng F
Biomedicines; 2023 Oct; 11(10):. PubMed ID: 37893066
[TBL] [Abstract][Full Text] [Related]
8. Dexmedetomidine Attenuates Ferroptosis-Mediated Renal Ischemia/Reperfusion Injury and Inflammation by Inhibiting ACSL4
Tao WH; Shan XS; Zhang JX; Liu HY; Wang BY; Wei X; Zhang M; Peng K; Ding J; Xu SX; Li LG; Hu JK; Meng XW; Ji FH
Front Pharmacol; 2022; 13():782466. PubMed ID: 35873574
[TBL] [Abstract][Full Text] [Related]
9. ACSL4 deficiency confers protection against ferroptosis-mediated acute kidney injury.
Wang Y; Zhang M; Bi R; Su Y; Quan F; Lin Y; Yue C; Cui X; Zhao Q; Liu S; Yang Y; Zhang D; Cao Q; Gao X
Redox Biol; 2022 May; 51():102262. PubMed ID: 35180475
[TBL] [Abstract][Full Text] [Related]
10. Ferroptosis involves in renal tubular cell death in diabetic nephropathy.
Wang Y; Bi R; Quan F; Cao Q; Lin Y; Yue C; Cui X; Yang H; Gao X; Zhang D
Eur J Pharmacol; 2020 Dec; 888():173574. PubMed ID: 32976829
[TBL] [Abstract][Full Text] [Related]
11. Necroptosis and ferroptosis are alternative cell death pathways that operate in acute kidney failure.
Müller T; Dewitz C; Schmitz J; Schröder AS; Bräsen JH; Stockwell BR; Murphy JM; Kunzendorf U; Krautwald S
Cell Mol Life Sci; 2017 Oct; 74(19):3631-3645. PubMed ID: 28551825
[TBL] [Abstract][Full Text] [Related]
12. [Effect and mechanism of Jiedu Huoxue Decoction in regulating YAP/ACSL4 pathway to inhibit ferroptosis in treatment of acute kidney injury].
Cheng R; Tian RM; Huang LH; Wang XW; Guo S; Wu AJ; Li C; Chen J; Li SJ; Chen M; Mao W; Xu P
Zhongguo Zhong Yao Za Zhi; 2024 Jan; 49(1):151-161. PubMed ID: 38403348
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of cisplatin-induced Acsl4-mediated ferroptosis alleviated ovarian injury.
Wang S; Li X; Li J; Wang A; Li F; Hu H; Long T; Pei X; Li H; Zhong F; Zhu F
Chem Biol Interact; 2024 Jan; 387():110825. PubMed ID: 38056807
[TBL] [Abstract][Full Text] [Related]
14. Repositioning of FDA-Approved antifungal agents to interrogate Acyl-CoA synthetase long chain family member 4 (ACSL4) in ferroptosis.
Marteau R; Ravez S; Mazhari Dorooee D; Bouchaoui H; Porte K; Devedjian JC; Melnyk P; Devos D; Frédérick R; El Bakali J
Biochem Pharmacol; 2022 Oct; 204():115239. PubMed ID: 36075462
[TBL] [Abstract][Full Text] [Related]
15. Vitexin attenuates chronic kidney disease by inhibiting renal tubular epithelial cell ferroptosis via NRF2 activation.
Song J; Wang H; Sheng J; Zhang W; Lei J; Gan W; Cai F; Yang Y
Mol Med; 2023 Oct; 29(1):147. PubMed ID: 37891461
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of Acyl-CoA Synthetase Long-Chain Family Member 4 Facilitates Neurological Recovery After Stroke by Regulation Ferroptosis.
Chen J; Yang L; Geng L; He J; Chen L; Sun Q; Zhao J; Wang X
Front Cell Neurosci; 2021; 15():632354. PubMed ID: 33889074
[TBL] [Abstract][Full Text] [Related]
17. Acyl-CoA synthase ACSL4: an essential target in ferroptosis and fatty acid metabolism.
Ding K; Liu C; Li L; Yang M; Jiang N; Luo S; Sun L
Chin Med J (Engl); 2023 Nov; 136(21):2521-2537. PubMed ID: 37442770
[TBL] [Abstract][Full Text] [Related]
18. MiR-20a-5p alleviates kidney ischemia/reperfusion injury by targeting ACSL4-dependent ferroptosis.
Shi L; Song Z; Li Y; Huang J; Zhao F; Luo Y; Wang J; Deng F; Shadekejiang H; Zhang M; Dong S; Wu X; Zhu J
Am J Transplant; 2023 Jan; 23(1):11-25. PubMed ID: 36695612
[TBL] [Abstract][Full Text] [Related]
19. Selenium binding protein 1 protects renal tubular epithelial cells from ferroptosis by upregulating glutathione peroxidase 4.
Zhao W; Nikolic-Paterson DJ; Li K; Li Y; Wang Y; Chen X; Duan Z; Zhang Y; Liu P; Lu S; Fu R; Tian L
Chem Biol Interact; 2024 Apr; 393():110944. PubMed ID: 38518851
[TBL] [Abstract][Full Text] [Related]
20. Involvement of FATP2-mediated tubular lipid metabolic reprogramming in renal fibrogenesis.
Chen Y; Yan Q; Lv M; Song K; Dai Y; Huang Y; Zhang L; Zhang C; Gao H
Cell Death Dis; 2020 Nov; 11(11):994. PubMed ID: 33219209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
